Early Stage Triple-Negative Breast Carcinoma

molecular subtype

Identifier: CI-CAN-00005136
Entity page: /cancer/early-stage-triple-negative-breast-carcinoma ↗
Edges: 20

Neighbours: 10 drugs10 trials
Drawn: 20 of 20 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Early Stage Triple-Negative Breast Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Pembrolizumabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants	—	—	Early Stage Triple-Negative Breast Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants

Early Stage Triple-Negative Breast Carcinoma studied in …STUDIED_INderived10 of 10
→ studied in	NCT07407920Phase 2 · recruiting Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06610097NA · withdrawn TNBC Gut Microbiota During Neoadjuvant Treatment · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05812807Phase 3 · recruiting Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07552181Phase 2 · not yet recruiting Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07017673Phase 2 · recruiting Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07486687Phase 3 · not yet recruiting Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06349642recruiting Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06324240Phase 1 · recruiting Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05929768Phase 3 · recruiting Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05774886Phase 1 · withdrawn Implantable Microdevice for TNBC - Pilot Study · condition mapped ONTOLOGY_EXACT · 10 trials mapped (8 active)	—	—	Early Stage Triple-Negative Breast Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains